Pembrolizumab, Quavonlimab

8 trials 1 recruiting

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

1 Recruiting

7 Completed trials

1 Sponsors

20 Countries

Phase III

Phase II/III

Phase II

Phase I/II

Phase III: 1 Phase II/III: 1 Phase II: 1 Phase I/II: 5

Oversight events:

1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Renal cell carcinoma 2 Colorectal cancer stage IV 1 Small cell lung cancer extensive stage 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 8

All trials

8 total

A clinical study of different treatments for kidney cancer (MK-3475-03A) Recruiting

2023-506838-68-00 Phase I/II 5 countries Merck Sharp & Dohme LLC
A clinical study of pembrolizumab with other study treatments in people with refractory lung cancer (MK-3475-B98) Ended

2023-507687-38-00 Phase I/II 5 countries Merck Sharp & Dohme LLC
A Multi Arm Study in Participants with MSI-High Metastatic Colorectal Cancer Ended

2022-502100-70-00 Phase II/III 13 countries Merck Sharp & Dohme LLC
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended

2022-502122-41-00 Phase III 14 countries Merck Sharp & Dohme LLC
A clinical study of different treatments for kidney cancer (MK-3475-03B) Ended

2023-506839-15-00 Phase I/II 5 countries Merck Sharp & Dohme LLC
Phase 2 Study of MK-1308A (Coformulated MK-1308/MK-3475), plus Lenvatinib (E7080/MK-7902) in First-line Therapy of Advanced Hepatocellular C… Ended

2023-505698-34-00 Phase II 3 countries Merck Sharp & Dohme LLC
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain M… Ended

2023-506315-17-00 Phase I/II 6 countries Merck Sharp & Dohme LLC
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants with Melanoma (KEYMAK… Ended

2023-506313-21-00 Phase I/II 6 countries Merck Sharp & Dohme LLC

Showing 1–8 of 8 trials

← All drugs A–Z